Current Headlines

  1. Phillips-Medisize Corp. Appoints Richard Even As GM Of Medical Campus In Menomonie Wisconsin
    5/23/2016

    Phillips-Medisize Corporation recently announced the appointment of Richard Even as General Manager of BioPharma and the medical campus in Menomonie Wisconsin. This is the latest in a series of strategic hires driven by the company’s continued growth in biopharma drug delivery devices, consumable diagnostics, and medical devices.

  2. EndoChoice Announces FDA Clearance Of Sterile, Single-Use Suction Valves
    5/23/2016

    EndoChoice Holdings, Inc. (NYSE: GI) announced it received 510(k) clearance for its new Orca™ sterile, single-use air/water and suction valves for Olympus® 160, 180 and 190 Series flexible endoscopes.

  3. Cryoport Provides Cold Chain Support For Phase I Parkinson's Trial
    5/23/2016

    Cryoport, Inc. (NASDAQ: CYRX) ("Company"), the world's leading cryogenic logistics company for the life sciences industry, today announced that it will provide global logistics support to International Stem Cell Corporation's (OTCQB: ISCO) ("ISCO") for its Phase I clinical trial in Australia for the treatment of moderate to severe Parkinson's disease.

  4. GlobalVision Quality Control Platform Now Embedded Within Esko Automation Engine
    5/19/2016

    GlobalVision, the world leader in the development of innovative proofreading technologies, recently announced that it will be demonstrating for the first time at drupa 2016 the integration of its Quality Control Platform into Esko’s Automation Engine 16.

  5. Bristol-Myers Squibb Opens Expanded Biologics Facility
    5/17/2016

    Bristol-Myers Squibb recently celebrated the completion of a major expansion at its Devens, MA biologics facility designed to accelerate development of the company’s growing portfolio of biologics medicines.

  6. Sartorius Stedim Biotech Releases New Poster On ambr 15 Fermentation Micro Scale Bioreactor System
    5/12/2016

    Sartorius Stedim Biotech (SSB) recently announced a poster presented at BPI Europe, entitled, ‘A novel automated micro bioreactor for high density fed batch microbial screening applications’ is now available online.

  7. JHL Biotech Opens Innovative Biosimilars Manufacturing Facility In China
    5/10/2016

    JHL Biotech (JHL), a biopharmaceutical company, opened the world’s first KUBio biopharmaceutical manufacturing facility with single-use bioprocessing technology at a ribbon-cutting ceremony in Wuhan, China today.

  8. PGD Names Douglas Ward As Chief Executive Officer
    5/9/2016

    Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome testing products and services, today announced that Douglas Ward has joined the company as Chief Executive Officer and a member of the board of directors.

  9. U.S. FDA Expands IMBRUVICA Label To Include Overall Survival Data
    5/9/2016

    AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) updated the IMBRUVICA® (ibrutinib) Prescribing Information (PI) to include new data from two Phase 3 trials supporting its expanded use in patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).[1].

  10. Avelas Biosciences Announces Positive Interim Phase 1b Results
    5/9/2016

    Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced positive interim results from a Phase 1b trial of its AVB-620 surgical marker in women with primary, non-recurrent breast cancer undergoing surgery.